Regeneron Pharmaceuticals (REGN) Gets Bernstein Lower Rating; Giga-tronics (GIGA) Shorts Decreased By 25.93%

June 26, 2017 - By Stephen Andrade

Among 22 analysts covering Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), 11 have Buy rating, 0 Sell and 11 Hold. Therefore 50% are positive. Regeneron Pharmaceuticals Inc. has $700 highest and $300 lowest target. $547.15’s average target is 5.93% above currents $516.51 stock price. Regeneron Pharmaceuticals Inc. had 50 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Chardan Capital Markets given on Monday, December 12. Roth Capital maintained the shares of REGN in report on Monday, April 4 with “Buy” rating. As per Tuesday, August 4, the company rating was maintained by Chardan Capital Markets. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, August 5. The firm has “Buy” rating given on Friday, December 16 by BTIG Research. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has “Outperform” rating given on Friday, December 4 by Wells Fargo. The stock of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned “Outperform” rating by Leerink Swann on Friday, February 5. The rating was initiated by Raymond James with “Outperform” on Tuesday, September 1. Canaccord Genuity downgraded the stock to “Hold” rating in Wednesday, January 27 report. The stock has “Buy” rating by Roth Capital on Tuesday, January 19.

Giga-tronics Incorporated (NASDAQ:GIGA) had a decrease of 25.93% in short interest. GIGA’s SI was 85,400 shares in June as released by FINRA. Its down 25.93% from 115,300 shares previously. With 81,500 avg volume, 1 days are for Giga-tronics Incorporated (NASDAQ:GIGA)’s short sellers to cover GIGA’s short positions. The SI to Giga-tronics Incorporated’s float is 1.23%. About 26,666 shares traded. Giga-tronics, Incorporated (NASDAQ:GIGA) has declined 26.56% since June 26, 2016 and is downtrending. It has underperformed by 43.26% the S&P500.

Investors sentiment decreased to 0.5 in Q4 2016. Its down 0.67, from 1.17 in 2016Q3. It dived, as 2 investors sold Giga-tronics, Incorporated shares while 4 reduced holdings. 0 funds opened positions while 3 raised stakes. 269,675 shares or 25.73% less from 363,107 shares in 2016Q3 were reported. Natl Bank Of America De reported 0% of its portfolio in Giga-tronics, Incorporated (NASDAQ:GIGA). Millennium Limited Liability Company owns 10,300 shares. Vanguard Grp Inc has invested 0% of its portfolio in Giga-tronics, Incorporated (NASDAQ:GIGA). Kcg Hldgs Incorporated accumulated 11,127 shares. Blackrock Fund Advsrs has invested 0% of its portfolio in Giga-tronics, Incorporated (NASDAQ:GIGA). Geode Management Limited Liability Com has 0% invested in Giga-tronics, Incorporated (NASDAQ:GIGA) for 19,463 shares. Moreover, Mirador Cap Prns Ltd Partnership has 0.02% invested in Giga-tronics, Incorporated (NASDAQ:GIGA). The New York-based Goldman Sachs has invested 0% in Giga-tronics, Incorporated (NASDAQ:GIGA). California Employees Retirement Sys has 126,700 shares for 0% of their portfolio. Manufacturers Life Insur The owns 769 shares for 0% of their portfolio. Northern Tru invested 0% of its portfolio in Giga-tronics, Incorporated (NASDAQ:GIGA).

Giga-tronics Incorporated includes the activities of the Giga-tronics Division and Microsource Inc. (Microsource). The company has market cap of $8.24 million. The Firm operates through two divisions: Giga-tronics Division and Microsource. It currently has negative earnings. Giga-tronics segment designs, makes and markets the Advanced Signal Generator (ASG) for the electronic warfare market and switching systems that are used in automatic testing systems primarily in aerospace, defense and telecommunications.

Investors sentiment increased to 1.25 in Q4 2016. Its up 0.29, from 0.96 in 2016Q3. It increased, as 48 investors sold Regeneron Pharmaceuticals Inc shares while 151 reduced holdings. 60 funds opened positions while 188 raised stakes. 70.27 million shares or 1.15% less from 71.09 million shares in 2016Q3 were reported. California State Teachers Retirement Systems invested in 0.12% or 161,670 shares. Joel Isaacson And Lc reported 0.22% stake. Lombard Odier Asset Mngmt (Europe) reported 955 shares. Hartford Invest Mgmt holds 0.12% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 18,153 shares. Ls Advsr Ltd Liability Corporation invested in 1,835 shares. Dekabank Deutsche Girozentrale invested 0.28% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). 7,747 were reported by Fiera Cap. Panagora Asset Inc invested 0.11% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Moreover, Pictet Asset Mgmt has 0.43% invested in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Cibc World Markets Corp accumulated 5,207 shares. Stanley, a Alabama-based fund reported 2,977 shares. Leavell Investment has 3,440 shares. Hl Ser Limited Liability holds 738 shares. France-based Credit Agricole S A has invested 0.02% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN). Advantus Cap Management holds 7,647 shares.

About 672,611 shares traded. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has risen 17.40% since June 26, 2016 and is uptrending. It has outperformed by 0.70% the S&P500.